Panda Intel: Issue 5
Welcome back to Panda Intel!
In this edition, we look at how AI is enhancing data integrity in clinical trials through improved accuracy and faster delivery. We also share an exciting press release, all about Panda leading the way in the life sciences industry!
Additionally, we share some fascinating industry news covering the impact of AI on the pharmaceutical industry, from addressing cybersecurity skills gaps to revolutionising drug discovery methods with impressive success rates.
Subscribe and stay ahead with Panda Intel, where innovation meets insight.
AI and Data Integrity for Clinical Trials
In our latest blog, we look at how AI is transforming clinical trials through improved data accuracy, streamlining review processes, and accelerating timelines.
We also discuss the future potential of AI in creating more patient-centric trials and personalised treatments, and the role that AI plays in continuing to support advanced clinical research.
Panda Leads the Charge in Life Sciences: A Standout in the Top 250 fastest growing companies in the Netherlands
Panda is proud to announce our recognition as one of the Top 250 fastest-growing companies in the Netherlands for 2024, as highlighted by the Erasmus Centre for Entrepreneurship. This prestigious accolade is a testament to our relentless drive and specialised focus within the life sciences sector. As the only recruitment consultancy in our field to be recognised, this honour not only showcases our unique position but also reinforces our commitment to advancing the industry by connecting top talent with leading-edge companies.
This achievement reflects our impact and dedication to fueling growth and facilitating scientific advancements across the Biotech, Pharma, MedTech, and Intelligence sectors. Our CEO, Jay Freeman, expresses gratitude and excitement about this recognition, emphasising Panda’s important role in shaping the future of life sciences through talent acquisition.
We're thrilled to share this milestone with our community and look forward to continuing our work in driving forward the life sciences industry.
Read more about our journey and the Top 250 list here.
Industry News:
Artificial Intelligence: The Saviour of the Pharmaceutical Industry
AI’s potential to revolutionise the pharmaceutical industry was a key topic at the UK’s Pharmaceutical Industry Networking Group (PING) meeting in June. This article discusses the critical questions and discussions around AI’s impact on the sector. Read More Here.
How Life Science Companies use AI to fill the cyber security skills gap
According to Code42, 73% of Life Sciences companies are leveraging AI to address the cyber security skills gaps, outpacing other industries. This article highlights how under-resourced security teams are managing an increase in insider data-driven loss events. Click here to learn more.
The roadmap to effective AI-driven drug development
Generative AI has had a significant impact on the pharmaceutical industry. For example, although many are moving away from traditional drug discovery methods, moving towards more efficient and cost-effective solutions can achieve the same outcome. With a success rate of 80-90%, AI is reshaping how new drugs are developed. Read more here.
If you want to be the first to know when the next instalment is available, subscribe to receive all future publications directly in your inbox.